Login to Your Account

Evaluating the value proposition: NICE chief sets conciliatory tone

By Cormac Sheridan
Staff Writer

Thursday, September 22, 2016

DUBLIN – Even if much of the focus of the inaugural Biopharma Ambition meeting here was on how Ireland can compete to win more investment from the global biopharma industry, scheduling Sir Andrew Dillon, CEO of NICE, suggested a certain amount of realism on the part of the conference organizers.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription